Status In progress
Process STA 2018
ID number 1221

Project Team

Project lead Marcia Miller

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
30 May 2018 As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of ibrutinib for untreated mantle cell lymphoma. Following an update from the company, the timelines for this appraisal are to be confirmed in order to align with latest regulatory expectations. Therefore, NICE will continue to monitor development and will update interested parties as and when the situation changes.
26 June 2017 In progress, Topic referred
22 July 2016 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance